Skip to Main Content

Paper Details

Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD-positive blood products in trauma.
Transfusion
3
2023
Author NameAffiliation
Cassandra D JosephsonCancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital
Cassandra D JosephsonJohns Hopkins University School of Medicine
Pampee P YoungVanderbilt University Medical Center
Pampee P Young
Philip C SpinellaTrauma and Transfusion Medicine Research Center, University of Pittsburgh
Philip C SpinellaUniversity of Pittsburgh
  • 1 - 6

Datasets